TURNSTONE BIOLOGICS CORP (TSBX) Stock Cash Flow
NASDAQ:TSBX - Nasdaq - US90042W1009 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -63.01M | -70.84M | -55.20M | -30.83M | 33.27M | |||
| Depreciation Amortization | 1.63M | 1.83M | 2.80M | 3.90M | 1.39M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | 0.00 | -101.00K | |||
| Change In Working Capital | 439.00K | 47.00K | -17.92M | -57.97M | -85.65M | |||
| Taxes Paid | 312.00K | 196.00K | 100.00K | N/A | N/A | |||
| Other non cash items | 3.88M | 1.52M | 4.17M | 13.84M | 5.47M | |||
| OPERATING CASH FLOW | -57.07M | -67.44M | -66.15M | -71.06M | -45.63M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -229.00K | -1.25M | -5.17M | -3.41M | |||
| Other Investing Activity | 64.56M | 78.78M | -26.84M | -9.76M | 58.00K | |||
| INVESTING CASH FLOW | 64.47M | 78.56M | -28.09M | -14.93M | -3.35M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | N/A | 44.00K | 77.94M | 157.00K | 79.95M | |||
| Other Financing Activity | N/A | -33.00K | -898.00K | -2.81M | N/A | |||
| FINANCING CASH FLOW | N/A | 11.00K | 77.05M | -2.66M | 79.95M | |||
| CHANGE IN CASH | 7.41M | 11.13M | -17.20M | -88.65M | 30.98M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -57.07M | -67.44M | -66.15M | -71.06M | -45.63M | |||
| Capital Expenditure | N/A | -229.00K | -1.25M | -5.17M | -3.41M | |||
| FREE CASH FLOW | -57.15M | -67.67M | -67.40M | -76.23M | -49.03M | |||
All data in USD